Gennex Laboratories Limited has submitted a formal response to BSE Limited regarding significant price movement observed in the company's securities on the exchange. The communication is dated 26th May, 2026 and is in reference to Regulation 30 of SEBI (LODR) Regulations, 2015.
The company was responding to an email from BSE dated 25th May, 2026, where the exchange sought clarification regarding significant movement noticed in the price of the company's security in the recent past.
In its response, Gennex Laboratories confirmed that:
- The company has not made any announcement (including any impending announcement)
- The company has not shared any information of significance in the public domain
- No disclosed information would have a bearing on the price/volume behaviour noted by the exchange
The company stated that the price movement is not attributable to any announcement or information shared by the company, but is consistent with normal market behaviour driven by varied external factors.
Gennex Laboratories reiterated its commitment to disclose any price-sensitive information or announcement to the exchange in compliance with applicable regulations as a matter of standard practice.
The response was digitally signed by Dinesh Kumar Kejriwal, Company Secretary & Compliance Officer (DIN), with membership number A19293, on 26th May, 2026 at 16:38:41.